Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults
Clinical trial NCT04911790 · COMPLETED
Trial details
- NCT number
- NCT04911790
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-05
- Primary completion
- 2023-01-02
- Enrollment
- 131650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.